The Center for Transformational Psychotherapy

The Premiere Ketamine Therapy Provider in The San Francisco Bay Area

COVID-19 Requirements for in-person sessions

Announcements

 
just published online in the Journal of Psychoactive Drugs (click link above to read)

The Ketamine Research Foundation (KRF)is proud to present its research on the presence/absence of ketamine in breast milk. As a first line antidepressant, ketamine in assisted psychotherapy (KAP) for women who are breast-feeding and suffering with postpartum depression (PPD), and depression and PTSD offers the option for intermittent use. This solves the dilemma for women seeking effective treatment and who do not wish to expose infants to  continuous exposure to conventional treatments such as antidepressants. As the effects of long term continuous use of medication on infant development is unknown and difficult to study prospectively, the assurance of our study opens the door to a different and effective approach.

KRF is in the process of developing its protocol for PPD and we expect to launch in the Fall.

 Contributions to our 501c3 Ketamine Research Foundation are deeply appreciated: ketamineresearchfoundation.org

Read the New Yorker Article that mentions our work here: Ketamine Therapy Is Going Mainstream. Are We Ready?

CTP/Phil Wolfson named by Double Blind online mag as a best Bay Area Ketamine Clinic!

Read our Latest Paper:
Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy

KRF is pleased to announce Wolfson, Andries, et al’s study of the MAPS sponsored MDMA and Life Threatening Illness,
this as KRF begins its study of KAP for Life Threatening Illness
. READ MORE

KAP is focused on healing old trauma and habitual ways of being that don’t serve our highest selves, PTSD, eating-disorders, addiction, and relational work. KAP treatment has evolved to support patient’s need for a safe counter to discover the parts themselves that can be made whole and reclamation of the truest self.

Our practice tends to be to work as a male/female team, this emanates from our collaborative work in the MAPS sponsored MDMA trial. Our therapeutic teams work in diads to support patients through their healing journey.

After the determination if ketamine is to be used, a decision is made together as to which method will commence treatment. Most often we begin with a lozenge session to acquaint patients with the ketamine experience, to assess sensitivity and responsivity, dosage, and to design the at-home experience.

Thank you so much for your interest!